VOLUME 13, ISSUE 6 / JUNE 2021
Editorial
MAY 2021
Glycoproteomic bioanalysis of exosomes by LC–MS for early diagnosis of pancreatic cancer
- Mingming Xu
, - Wenhua Hu ,
- Zhaoliang Liu ,
- Jun Xia ,
- Sufeng Chen ,
- Perry G Wang &
- Shuang Yang
- Pages:861–864
- Published Online:18 May 2021
Methodology
MAY 2021
Quantitative determination of Cpd118, A novel FBPase inhibitor, in dog plasma by HPLC–MS/MS
- Jinping Hu ,
- Jie Zhou,
- Yanhong Sun,
- Huixin Tan,
- Fenghe Wang,
- Shuainan Liu,
- Bailing Xu,
- Yan Li &
- Zhufang Shen
- Pages:865–873
- Published Online:17 May 2021
Research Article
MAY 2021
Quantitation of ivosidenib in human plasma via LC–MS/MS and its application in clinical trials
- Feng Yin,
- Shaoxia Yu,
- Rohini Narayanaswamy,
- Heidi Mangus,
- Erin McCourt &
- Guowen Liu
- Pages:875–889
- Published Online:17 May 2021
Research Article
APRIL 2021
Comparing singlet and duplicate immunogenicity assay in human plasma for pembrolizumab using Gyrolab®
- Johannes L Stanta ,
- Hannah Craig,
- Christopher Smith &
- John Chappell
- Pages:891–900
- Published Online:30 April 2021
Review
MAY 2021
The role of ligand-binding assay and LC–MS in the bioanalysis of complex protein and oligonucleotide therapeutics
- Srikanth Kotapati ,
- Madhura Deshpande,
- Aarti Jashnani ,
- Dharam Thakkar,
- Hongwu Xu &
- Gavin Dollinger
- Pages:931–954
- Published Online:17 May 2021